MIRA Pharmaceuticals, Correlations
MIRA Stock | 1.10 0.05 4.35% |
The correlation of MIRA Pharmaceuticals, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
MIRA Pharmaceuticals, Correlation With Market
Good diversification
The correlation between MIRA Pharmaceuticals, Common and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MIRA Pharmaceuticals, Common and DJI in the same portfolio, assuming nothing else is changed.
MIRA |
Moving against MIRA Stock
0.51 | GILD | Gilead Sciences | PairCorr |
0.47 | LLY | Eli Lilly | PairCorr |
0.39 | AZN | AstraZeneca PLC ADR | PairCorr |
0.33 | OCX | OncoCyte Corp | PairCorr |
0.32 | SNY | Sanofi ADR | PairCorr |
0.45 | DRMAW | Dermata Therapeutics | PairCorr |
0.4 | AMGN | Amgen Inc | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MIRA Stock performing well and MIRA Pharmaceuticals, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MIRA Pharmaceuticals,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NWMH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
APAM | 1.35 | (0.03) | 0.00 | (0.02) | 0.00 | 2.41 | 9.44 | |||
AMBI | 3.14 | 0.06 | 0.02 | 0.18 | 3.71 | 7.29 | 21.19 | |||
EMR | 1.22 | (0.10) | 0.00 | (0.08) | 0.00 | 2.13 | 9.68 | |||
EFRMF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CG | 2.00 | (0.05) | 0.00 | (0.03) | 0.00 | 3.25 | 10.93 | |||
ELVA | 2.99 | 0.26 | 0.09 | 4.76 | 2.92 | 7.54 | 17.61 | |||
CRESY | 2.07 | (0.15) | 0.00 | (0.40) | 0.00 | 4.24 | 11.90 |
MIRA Pharmaceuticals, Corporate Executives
Elected by the shareholders, the MIRA Pharmaceuticals,'s board of directors comprises two types of representatives: MIRA Pharmaceuticals, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MIRA. The board's role is to monitor MIRA Pharmaceuticals,'s management team and ensure that shareholders' interests are well served. MIRA Pharmaceuticals,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MIRA Pharmaceuticals,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
Michelle MBA | Secretary CFO | Profile |